GLOMERULOSCLEROSIS side effect
What is GLOMERULOSCLEROSIS ?Drugs associated with GLOMERULOSCLEROSIS
ACCUTANE AZASAN COLAZAL EXJADE LIPITOR NEORAL PHOSPHOSODA TYGACILGLOMERULOSCLEROSIS : Exjade Side Effects Report #5599569-3
Physician from GREECE reported EXJADE problem on Jan 17, 2008. Female patient, 38 years of age, weighting 154.3 lb, was diagnosed with blood iron increased, hypogonadism, platelet count increased and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, proteinuria, renal impairment, . EXJADE dosage: 1500 MG, QD. During the same period patient was treated with COMBIPATCH, SALOSPIR. Patient recovered.
GLOMERULOSCLEROSIS : Phosphosoda Side Effects Report #5422137-0
PHOSPHOSODA FLAVOR NOT SPECIFIED problem was reported by a Physician from UNITED STATES on Aug 21, 2007. Female patient, 60 years of age, was diagnosed with colonoscopy and was treated with PHOSPHOSODA FLAVOR NOT SPECIFIED. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, kidney fibrosis, nephritis interstitial, nephrocalcinosis, nephrosclerosis, post procedural complication, renal failure acute, renal ischaemia, renal tubular disorder, . PHOSPHOSODA FLAVOR NOT SPECIFIED dosage: unknown. Patient recovered.
GLOMERULOSCLEROSIS : Neoral Side Effects Report #5386204-2
Consumer or non-health professional from JAPAN reported NEORAL problem on July 05, 2007. Male patient, 15 years of age, weighting 136.7 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, kidney fibrosis, nephropathy toxic, nephrotic syndrome, therapeutic response decreased, . NEORAL dosage: 125 MG/DAY. Patient recovered.
GLOMERULOSCLEROSIS : Neoral Side Effects Report #5386204-2
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on July 05, 2007. Male patient, 15 years of age, weighting 136.7 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, kidney fibrosis, nephropathy toxic, nephrotic syndrome, therapeutic response decreased, . NEORAL dosage: 125 MG/DAY. Patient recovered.
GLOMERULOSCLEROSIS : Neoral Side Effects Report #5598175-4
Consumer or non-health professional from JAPAN reported NEORAL problem on Jan 17, 2008. Male patient, 15 years of age, weighting 136.7 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: chronic sinusitis, glomerulosclerosis, haemoglobin decreased, kidney fibrosis, nephritis, nephropathy toxic, nephrotic syndrome, protein urine present, therapeutic response decreased, . NEORAL dosage: 125 MG/DAY. Patient recovered.
GLOMERULOSCLEROSIS : Azasan Side Effects Report #5510687-8
AZASAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 29, 2007. Male patient, 33 years of age, was diagnosed with colitis ulcerative and was treated with AZASAN. After drug was administered, patient experienced the following problems/side effects: dehydration, glomerulosclerosis, kidney fibrosis, meniere's disease, nephritis interstitial, pyrexia, renal arteriosclerosis, renal failure acute, renal tubular atrophy, . AZASAN dosage: 50 MG;QD;. During the same period patient was treated with COLAZAL, PRIMAL DEFENSE, PREDNISONE, MECLIZINE. Patient was hospitalized. Patient recovered.
GLOMERULOSCLEROSIS : Colazal Side Effects Report #5505139-5
Physician from UNITED STATES reported COLAZAL problem on Oct 23, 2007. Male patient, 33 years of age, weighting 183.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: dehydration, glomerulosclerosis, nephritis interstitial, pyrexia, renal failure acute, renal tubular necrosis, . COLAZAL dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PRIMAL DEFENSE, PREDNISONE, MECLIZINE. Patient was hospitalized and became disabled. Patient recovered.
GLOMERULOSCLEROSIS : Lipitor Side Effects Report #5376391-4
LIPITOR problem was reported by a Physician from AUSTRALIA on June 21, 2007. Male patient, 74 years of age, was diagnosed with trichophytosis and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, nephrosclerosis, . LIPITOR dosage: unknown. During the same period patient was treated with LAMISIL. Patient recovered.
GLOMERULOSCLEROSIS : Neoral Side Effects Report #5388992-8
Consumer or non-health professional from JAPAN reported NEORAL problem on July 06, 2007. Male patient, 15 years of age, weighting 136.7 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: chronic sinusitis, glomerulosclerosis, kidney fibrosis, nephritis, nephropathy toxic, nephrotic syndrome, protein urine present, therapeutic response decreased, . NEORAL dosage: 125 MG/DAY. Patient recovered.
GLOMERULOSCLEROSIS : Lipitor Side Effects Report #5376391-4
LIPITOR problem was reported by a Physician from AUSTRALIA on June 21, 2007. Male patient, 74 years of age, was diagnosed with trichophytosis and was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, nephrosclerosis, . LIPITOR dosage: unknown. During the same period patient was treated with LAMISIL. Patient recovered.
GLOMERULOSCLEROSIS : Neoral Side Effects Report #5388992-8
Consumer or non-health professional from JAPAN reported NEORAL problem on July 06, 2007. Male patient, 15 years of age, weighting 136.7 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: chronic sinusitis, glomerulosclerosis, kidney fibrosis, nephritis, nephropathy toxic, nephrotic syndrome, protein urine present, therapeutic response decreased, . NEORAL dosage: 125 MG/DAY. Patient recovered.
GLOMERULOSCLEROSIS : Tygacil Side Effects Report #5621790-6
TYGACIL problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Male patient, weighting 217.4 lb, was diagnosed with decubitus ulcer, infection and was treated with TYGACIL. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, blood creatinine increased, glomerulosclerosis, intercapillary glomerulosclerosis, kidney fibrosis, nephritis interstitial, renal tubular atrophy, renal tubular disorder, . TYGACIL dosage: unknown. During the same period patient was treated with SEROQUEL, CELEXA, METOPROLOL TARTRATE, FOLATE, PROTONIX, ASPIRIN, ULTRAM. Patient was hospitalized. Patient recovered.
GLOMERULOSCLEROSIS : Accutane Side Effects Report #5599937-X
Physician from UNITED STATES reported ACCUTANE problem on Jan 17, 2008. Male patient, 14 years of age, weighting 198.0 lb, was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: epistaxis, fracture, glomerulosclerosis, multi-organ disorder, osteitis, proteinuria, renal disorder, renal failure, renal failure chronic, . ACCUTANE dosage: unknown. During the same period patient was treated with TYLENOL. Patient was hospitalized and became disabled. Patient recovered.